Substance Use Disorders: Conference Sessions

MGH 50th Annual Psychopharmacology Conference

October 16–18, 2026 · Boston, MA

• LectureAmplifying and Extending Effects of Addiction Treatment

  John F. Kelly

  Strategies for boosting and sustaining recovery outcomes beyond initial addiction treatment.

• SessionThe Neurobiology of Addiction

  Jodi Gilman

  Evening seminar on the brain mechanisms underlying substance use disorders.

  Neuroscience & Mechanisms

• LectureAmplifying and Extending the Effects of Addiction Treatment

  John F. Kelly

  Ways to enhance and sustain addiction treatment outcomes.

• LectureTreatment of Tobacco Use Disorders

  Anne Eden Evins

  Evidence-based approaches to helping patients quit smoking and nicotine use.

• PanelPanel Discussion

  John Fromson · Vinod Rao · Anne Eden Evins

  Faculty discussion on addiction treatment.

MasterPsych Psychiatry Conference 2026

October 19–22, 2026 · Newport Beach, CA

• LectureNew & Emerging Treatments for SUD

  Ximena Sanchez-Samper

  A three-hour review of newly available and pipeline treatments for substance use disorders.

  Drug Pipeline & Clinical Trials

• LectureNew & Emerging Treatments for Substance Use Disorders

  Ximena Sanchez-Samper

  Overview of new and emerging treatments for substance use disorders.

  Drug Pipeline & Clinical Trials

• LectureNew & Emerging Treatments for Substance Use D

  Ximena Sanchez-Samper

  Overview of new and emerging treatments for substance use disorders.

  Drug Pipeline & Clinical Trials

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• LectureEnvisioning a Continuum of Care for Adolescent Behavioral Addictions

  Sara J. Polley

  Explores how a continuum of care could be structured for adolescents with behavioral addictions.

  Child & Adolescent

• LectureEvolving Landscape of How Adolescents Game and Gamble

  Alexander Chevalier

  Overview of changing patterns of gaming and gambling among adolescents.

  Child & Adolescent

• LectureBetting on the Future: Gambling Disorders in Adolescents and Transitional-Age Youth

  Allison N. Chang

  Covers gambling disorders in adolescents and transitional-age youth.

  Child & Adolescent

• LectureCalculated Risk: Understanding Risk Factors for Adolescent Gambling Disorders

  Jennifer Creedon

  Examines risk factors associated with gambling disorders in adolescents.

  Child & Adolescent

• SymposiumFrom Roblox to Roulette: Gaming and Gambling Disorders in Adolescents and Transitional-Age Youth

  Jennifer Creedon · Gerald Busch · Alexander Chevalier · Allison N. Chang · Sara J. Polley

  Clinical perspectives on gaming and gambling disorders in adolescents and transitional-age youth.

  Child & Adolescent

See all 85 substance use disorders sessions at this meeting →

APNA 40th Annual Conference

October 28–31, 2026 · Phoenix, AZ

• WorkshopAn Addiction Primer for the Psychiatric Provider

  Justin Alves · Megan Hudson · Vanessa Loukas · Annie Potter

  Crash-course workshop on folding addiction treatment into everyday psychiatric practice, taught by an addictions nursing faculty team. Pharmacology-eligible.

• LectureMedetomidine in the Fentanyl Era: Emergence of a Veterinary Sedative as a Novel Adulterant

  Deborah Salani · Beatriz Valdes · Deana Goldin

  Overview of medetomidine appearing as an adulterant in the fentanyl supply, its potency, and implications for overdose management. Pharmacology-eligible.

  Drug Interactions & SafetyOpioid Use Disorder

• WorkshopNeuroplasticity in Substance Use Care: From Brain Development and Environmental Drivers to Integrated Treatment and Provider Resilience

  Laura Leahy · Susan Caverly · Lee Moore

  Connects neuroplasticity science and environmental determinants to youth substance use, recovery pathways, and clinician resilience.

  Child & AdolescentNeuroscience & Mechanisms

• WorkshopCo-Morbidities/Treatment & Provider Resilience

  Julie Perry · Shane Gallagher · Queen Henry-Okafor · Rosemary Smentkowski

  Combines neurobiology and resilience frameworks to improve treatment of substance use with co-occurring psychiatric conditions. Pharmacology-eligible.

  Neuroscience & Mechanisms

• LectureTreating Stimulant Use Disorders: Where to Start

  Megan Hudson · Justin Alves · Ogo George · D'Arcy Gebert

  Practical starting points for stimulant use disorder care, including overamping, stimulant-induced psychosis, and medication options. Pharmacology-eligible.

  Schizophrenia & Psychosis

See all 7 substance use disorders sessions at this meeting →

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• SymposiumBeyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development

  Christina Brezing · Frances Levin · Margaret Haney · John Mariani

  Argues for moving beyond abstinence as the sole endpoint in cannabis use disorder trials, discussing reduction-based and patient-centered outcome measures.

  Cannabis & CannabinoidsDrug Pipeline & Clinical Trials

• SymposiumFrom Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha

  Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.

  Alcohol Use DisorderGLP-1 & Metabolic Psychiatry

• SymposiumNeuromodulation to Treat Addictions: What's Available and What's in the Pipeline

  Manish Jha · Kathleen Brady · Hamed Ekhtiari · Gregory Sahlem · Brian Mickey

  Reviews current and investigational neuromodulation techniques for substance use disorders, including rTMS and focused ultrasound.

  Neuromodulation (ECT, TMS)Drug Pipeline & Clinical Trials

• SymposiumTobacco Use and Its Impact on Psychiatric Symptoms and the Recovery from Other Substance Use Disorders

  Maher Karam Hage · Jill Williams · Brian Hurley · Tony George

  Examines how ongoing tobacco use interacts with psychiatric symptoms and recovery from other substance use disorders.

• WorkshopAddiction, Hope, and Recovery in Tolkien's the Lord of the Rings

  Lisa Terris · James Berry

  Uses Tolkien's fiction as a lens for discussing addiction, hope, and recovery themes with patients and trainees.

  Education & TrainingPsychotherapy

See all 87 substance use disorders sessions at this meeting →

NPA 32nd Annual Psychopharmacology Update 2027

February 10–13, 2027 · Las Vegas, NV

• LectureADHD and Substance Use in Women: Recognition, Risks, and Treatment Considerations

  Mariely Hernandez

  How ADHD and substance use intersect in women, with guidance on recognition, risk assessment, and treatment planning.

  ADHDPerinatal & Women's Mental Health

• LectureTreatment of Methamphetamine Use Disorder

  Eleasa Sokolski

  Current pharmacologic and behavioral strategies for methamphetamine use disorder.

• LectureSexual Compulsivity

  Kenneth Rosenberg

  Assessment and treatment of compulsive sexual behavior in psychiatric practice.

  OCD & Related Disorders

Substance Use Disorders: A Comprehensive Review and Update 2027

February 15–17, 2027 · Lake Buena Vista, FL

• LectureNeurobiology of Addiction & Genetics of Substance Use Disorders

  Robert R. Althoff

  Covers the neurobiological basis of addiction and genetic contributions to substance use disorders.

  Neuroscience & Mechanisms

• LectureAdolescent Substance Use Disorders

  Robert R. Althoff

  Overview of substance use disorders in adolescents.

  Child & Adolescent

• LecturePain

  Jessica Gray

  Addresses pain management in patients with addiction.

  Opioid Use Disorder

• LectureADHD

  Timothy E. Wilens

  Discusses ADHD in relation to substance use risk and treatment.

  ADHD

• LecturePregnancy

  Jessica Gray

  Covers substance use treatment during pregnancy.

  Perinatal & Women's Mental Health

See all 24 substance use disorders sessions at this meeting →

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• SymposiumS18 – Closing the translational gap in addiction research: refining animal models for clinical impact

  Serge Ahmed · Kasia Radwanska · Steven Laviolette · Karen Ersche

  How refined animal models of alcohol, nicotine, and cannabis use can better inform addiction treatment.

  Alcohol Use DisorderNeuroscience & Mechanisms

WCP 2026 — 26th World Congress of Psychiatry

September 23–26, 2026 · Stockholm, Sweden

• CourseCourse 02: Psychopharmacology for Addiction Psychiatry: Recommendations, Clinical Guidelines and Case Scenarios

  Alexander Baldacchino · Hamed Ekhtiari

  Case-based course on guideline-concordant pharmacotherapy in addiction psychiatry.

• SymposiumState of the Art Symposium 01: Advances in Addiction and Dual Disorders
• PlenaryPlenary Session 07: Addiction Science as a Window into Brain Function

  Nora Volkow

  Nora Volkow's plenary on addiction neuroscience; the speakers page frames her talk around GLP-1 agonists and balancing neuro-metabolic opportunities with clinical realities.

  GLP-1 & Metabolic PsychiatryNeuroscience & Mechanisms

Medical Psychiatry: Comprehensive Update Conference 2026

September 17–20, 2026 · Online

• CourseInterface of Pain and Addiction in CL

  Claire Twark

  On-demand mini-course on managing patients where chronic pain and substance use disorders overlap.

  Medical Comorbidity & C-L Psychiatry

• LectureManagement of Substance Use Disorders in Pregnancy

  Sarah Bernstein

  Treatment approaches for pregnant patients with substance use disorders, balancing maternal and fetal considerations.

  Perinatal & Women's Mental Health

• LectureManagement of Substance Use Disorders in the Medical Setting

  David B. Hathaway

  Initiating and managing addiction treatment for patients hospitalized on medical services.

  Medical Comorbidity & C-L Psychiatry

• KeynoteKEYNOTE: GLP-1s & Management of Substance Use Disorders

  Joji Suzuki

  Emerging evidence on GLP-1 receptor agonists as potential treatments for addiction.

  GLP-1 & Metabolic Psychiatry

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA

• SymposiumCannabis Use and Mental Illness: What We Now Know (and Don't)

  Ilan Melnick · Andrew Penn

  Updates clinicians on cannabis-induced psychosis, mood effects, and dose-response data amid rising THC potency, with practical tapering strategies and treatment pathways for cannabis use disorder.

  Cannabis & CannabinoidsSchizophrenia & Psychosis

• LectureADHD With Comorbidities: Anxiety, Mood Disorders, Autism, and Substance Use Disorders

  Timothy E. Wilens

  Frameworks for diagnostic clarification and treatment sequencing when ADHD co-occurs with anxiety, mood disorders, autism, or substance use, balancing symptom control against misuse and destabilization risks.

  ADHDAnxiety DisordersAutism & Neurodevelopmental Disorders

• SymposiumNot All Delusions are Schizophrenia: Understanding Delusional Disorders and the Overlap with Substance Induced Psychosis

  Arwen Podesta · Andrew Penn

  Uses a historic case to teach differential diagnosis of psychosis beyond schizophrenia — substance-induced, delusional, and medical causes — including temporal analysis, labs, and imaging.

  Measurement-Based Care & DiagnosisSchizophrenia & Psychosis

• DebateSolving Clinical Challenges: Curbside Solutions for Complex Substance Use Disorder Cases

  Arwen Podesta · Veronica Ridpath · Lydia Bartholow

  Case-based panel dissecting complex opioid, stimulant, and withdrawal scenarios — including where system failures and clinical errors led to poor outcomes — with harm-reduction takeaways.

  Emergency & Acute PsychiatryOpioid Use Disorder